Detail Information of Transcriptional Regulations
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0175 Transporter Info | ||||
| Gene Name | SLC25A16 | ||||
| Transporter Name | Graves disease carrier protein | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Transcriptional Regulation of This DT (TSR) | ||||||
|---|---|---|---|---|---|---|
|
Class 1.1: Basic leucine zipper factors |
Click to Show/Hide the Full List of 4 TF(s) Regulating This DT |
|||||
|
ATF3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC25A16 gene | [1] | ||||
|
TF Protein Name |
Cyclic AMP-dependent transcription factor ATF-3 | Transcription Factor Info | ||||
|
Tissue |
Blood; Bone marrow; Colon | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Cyclic AMP-dependent transcription factor ATF-3 (ATF3) can directly bind to the SLC25A16 gene, which in turn affects the expression or function of the drug transporter Graves disease carrier protein. | |||||
|
CEBPA |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC25A16 gene | [2] | ||||
|
TF Protein Name |
CCAAT/enhancer-binding protein alpha | Transcription Factor Info | ||||
|
Tissue |
Blood; Liver | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
CCAAT/enhancer-binding protein alpha (CEBPA) can directly bind to the SLC25A16 gene, which in turn affects the expression or function of the drug transporter Graves disease carrier protein. | |||||
|
CEBPB |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC25A16 gene | [3] | ||||
|
TF Protein Name |
CCAAT/enhancer-binding protein beta | Transcription Factor Info | ||||
|
Tissue |
Bone | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
CCAAT/enhancer-binding protein beta (CEBPB) can directly bind to the SLC25A16 gene, which in turn affects the expression or function of the drug transporter Graves disease carrier protein. | |||||
|
CREB1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC25A16 gene | [4] | ||||
|
TF Protein Name |
Cyclic AMP-responsive element-binding protein 1 | Transcription Factor Info | ||||
|
Tissue |
Bone marrow; Embryo; Liver; Lung; Uterus | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Cyclic AMP-responsive element-binding protein 1 (CREB1) can directly bind to the SLC25A16 gene, which in turn affects the expression or function of the drug transporter Graves disease carrier protein. | |||||
|
Class 2.1: Nuclear receptors with C4 zinc fingers |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
|
AR |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC25A16 gene | [2] | ||||
|
TF Protein Name |
Androgen receptor | Transcription Factor Info | ||||
|
Tissue |
Breast; Cervix; Kidney; Prostate | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Androgen receptor (AR) can directly bind to the SLC25A16 gene, which in turn affects the expression or function of the drug transporter Graves disease carrier protein. | |||||
|
Class 2.2: Other C4 zinc finger-type factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
|
GATA3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC25A16 gene | [2] | ||||
|
TF Protein Name |
Trans-acting T-cell-specific transcription factor GATA-3 | Transcription Factor Info | ||||
|
Tissue |
Blood; Brain; Breast | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Trans-acting T-cell-specific transcription factor GATA-3 (GATA3) can directly bind to the SLC25A16 gene, which in turn affects the expression or function of the drug transporter Graves disease carrier protein. | |||||
|
Class 2.3: C2H2 zinc finger factors |
Click to Show/Hide the Full List of 5 TF(s) Regulating This DT |
|||||
|
KLF1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC25A16 gene | [3] | ||||
|
TF Protein Name |
Krueppel-like factor 1 | Transcription Factor Info | ||||
|
Tissue |
Blood | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Krueppel-like factor 1 (KLF1) can directly bind to the SLC25A16 gene, which in turn affects the expression or function of the drug transporter Graves disease carrier protein. | |||||
|
KLF4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC25A16 gene | [4] | ||||
|
TF Protein Name |
Krueppel-like factor 4 | Transcription Factor Info | ||||
|
Tissue |
Breast; Foreskin; Pancreatic ductal; Skin | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Krueppel-like factor 4 (KLF4) can directly bind to the SLC25A16 gene, which in turn affects the expression or function of the drug transporter Graves disease carrier protein. | |||||
|
KLF5 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC25A16 gene | [3] | ||||
|
TF Protein Name |
Krueppel-like factor 5 | Transcription Factor Info | ||||
|
Tissue |
Colon; Pancreatic ductal; Stomach | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Krueppel-like factor 5 (KLF5) can directly bind to the SLC25A16 gene, which in turn affects the expression or function of the drug transporter Graves disease carrier protein. | |||||
|
MAZ |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC25A16 gene | [1] | ||||
|
TF Protein Name |
Myc-associated zinc finger protein | Transcription Factor Info | ||||
|
Tissue |
Blood; Bone marrow; Cervix; Liver; Lung | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Myc-associated zinc finger protein (MAZ) can directly bind to the SLC25A16 gene, which in turn affects the expression or function of the drug transporter Graves disease carrier protein. | |||||
|
MECOM |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC25A16 gene | [4] | ||||
|
TF Protein Name |
Histone-lysine N-methyltransferase MECOM | Transcription Factor Info | ||||
|
Tissue |
Bone marrow | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Histone-lysine N-methyltransferase MECOM (MECOM) can directly bind to the SLC25A16 gene, which in turn affects the expression or function of the drug transporter Graves disease carrier protein. | |||||
|
Class 3.3: Fork head / winged helix factors |
Click to Show/Hide the Full List of 3 TF(s) Regulating This DT |
|||||
|
E2F1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC25A16 gene | [1] | ||||
|
TF Protein Name |
Transcription factor E2F1 | Transcription Factor Info | ||||
|
Tissue |
Mesenchymal | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Transcription factor E2F1 (E2F1) can directly bind to the SLC25A16 gene, which in turn affects the expression or function of the drug transporter Graves disease carrier protein. | |||||
|
FOXA1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC25A16 gene | [4] | ||||
|
TF Protein Name |
Hepatocyte nuclear factor 3-alpha | Transcription Factor Info | ||||
|
Tissue |
Breast; Liver; Pancreatic ductal; Prostate | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Hepatocyte nuclear factor 3-alpha (FOXA1) can directly bind to the SLC25A16 gene, which in turn affects the expression or function of the drug transporter Graves disease carrier protein. | |||||
|
FOXA2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC25A16 gene | [1] | ||||
|
TF Protein Name |
Hepatocyte nuclear factor 3-beta | Transcription Factor Info | ||||
|
Tissue |
Embryo; Liver; Lung; Skin | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Hepatocyte nuclear factor 3-beta (FOXA2) can directly bind to the SLC25A16 gene, which in turn affects the expression or function of the drug transporter Graves disease carrier protein. | |||||
|
Class 3.5: Tryptophan cluster factors |
Click to Show/Hide the Full List of 5 TF(s) Regulating This DT |
|||||
|
ERG |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC25A16 gene | [2] | ||||
|
TF Protein Name |
Transcriptional regulator ERG | Transcription Factor Info | ||||
|
Tissue |
Aorta | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Transcriptional regulator ERG (ERG) can directly bind to the SLC25A16 gene, which in turn affects the expression or function of the drug transporter Graves disease carrier protein. | |||||
|
ETS1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC25A16 gene | [3] | ||||
|
TF Protein Name |
Protein C-ets-1 | Transcription Factor Info | ||||
|
Tissue |
Blood; Bone; Bone marrow; Kidney; Prostate; Vein | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Protein C-ets-1 (ETS1) can directly bind to the SLC25A16 gene, which in turn affects the expression or function of the drug transporter Graves disease carrier protein. | |||||
|
FLI1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC25A16 gene | [3] | ||||
|
TF Protein Name |
Friend leukemia integration 1 transcription factor | Transcription Factor Info | ||||
|
Tissue |
Blood; Mesenchymal; Vein | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Friend leukemia integration 1 transcription factor (FLI1) can directly bind to the SLC25A16 gene, which in turn affects the expression or function of the drug transporter Graves disease carrier protein. | |||||
|
GABPA |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC25A16 gene | [4] | ||||
|
TF Protein Name |
GA-binding protein alpha chain | Transcription Factor Info | ||||
|
Tissue |
Blood; Bone marrow; Brain; Liver | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
GA-binding protein alpha chain (GABPA) can directly bind to the SLC25A16 gene, which in turn affects the expression or function of the drug transporter Graves disease carrier protein. | |||||
|
IRF1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC25A16 gene | [2] | ||||
|
TF Protein Name |
Interferon regulatory factor 1 | Transcription Factor Info | ||||
|
Tissue |
Blood; Bone marrow; Pancreatic ductal | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Interferon regulatory factor 1 (IRF1) can directly bind to the SLC25A16 gene, which in turn affects the expression or function of the drug transporter Graves disease carrier protein. | |||||
|
Class 10.1: Other factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
|
GTF2B |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC25A16 gene | [1] | ||||
|
TF Protein Name |
Transcription initiation factor IIB | Transcription Factor Info | ||||
|
Tissue |
Cervix; Lung | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Transcription initiation factor IIB (GTF2B) can directly bind to the SLC25A16 gene, which in turn affects the expression or function of the drug transporter Graves disease carrier protein. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.